These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11238343)

  • 21. Legal and economic perspectives concerning US government investigations of alleged off-label promotion by drug manufacturers.
    Kalb PE; Greenberg PE
    Pharmacoeconomics; 2009; 27(8):623-5. PubMed ID: 19835018
    [No Abstract]   [Full Text] [Related]  

  • 22. Pyrethrin and pyrethroid exposures in the United States: a longitudinal analysis of incidents reported to poison centers.
    Power LE; Sudakin DL
    J Med Toxicol; 2007 Sep; 3(3):94-9. PubMed ID: 18072143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Labeling and manufacturing standards proposed for all dietary supplements.
    Horrigan B; Block B
    Altern Ther Health Med; 2003; 9(3):22. PubMed ID: 12776471
    [No Abstract]   [Full Text] [Related]  

  • 24. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.
    Fed Regist; 2000 Jan; 65(1):7-9. PubMed ID: 11010625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2010 Jan; ():1-31. PubMed ID: 20217914
    [No Abstract]   [Full Text] [Related]  

  • 26. FDA's regulation of prescription drug labeling: a role for implied preemption.
    Kendrick LC
    Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031
    [No Abstract]   [Full Text] [Related]  

  • 27. Sixteen Years of Overregulation: Time to Unburden Mifeprex.
    ; Raymond EG; Blanchard K; Blumenthal PD; Cleland K; Foster AM; Gold M; Grossman D; Pendergast MK; Westhoff CL; Winikoff B
    N Engl J Med; 2017 Feb; 376(8):790-794. PubMed ID: 28225670
    [No Abstract]   [Full Text] [Related]  

  • 28. Toxicosis in cats erroneously treated with 45 to 65% permethrin products.
    Meyer EK
    J Am Vet Med Assoc; 1999 Jul; 215(2):198-203. PubMed ID: 10416472
    [No Abstract]   [Full Text] [Related]  

  • 29. FDA perspectives on supplement use by patients on antithrombotic therapy.
    Kim MJ
    Thromb Res; 2005; 117(1-2):197-200; discussion 201-7. PubMed ID: 16188297
    [No Abstract]   [Full Text] [Related]  

  • 30. AVMA legislation: partial solution to drug availability problem.
    Gloyd JS
    J Am Vet Med Assoc; 1993 Apr; 202(7):1055-6. PubMed ID: 8473213
    [No Abstract]   [Full Text] [Related]  

  • 31. Professional drug labeling.
    Terry M
    J Am Vet Med Assoc; 1993 May; 202(10):1711-2;discussion 1713-7. PubMed ID: 8514591
    [No Abstract]   [Full Text] [Related]  

  • 32. Regulating the safety of pharmaceuticals: the FDA, preemption, and the public's health.
    Gostin LO
    JAMA; 2009 May; 301(19):2036-7. PubMed ID: 19454642
    [No Abstract]   [Full Text] [Related]  

  • 33. FDA mulls over paperless labeling.
    Young D
    Am J Health Syst Pharm; 2007 Jun; 64(11):1120, 1122. PubMed ID: 17519446
    [No Abstract]   [Full Text] [Related]  

  • 34. Implications for the FDA/Center for Veterinary Medicine (CVM).
    Geyer RE
    J Am Vet Med Assoc; 1993 May; 202(10):1718-23. PubMed ID: 8514592
    [No Abstract]   [Full Text] [Related]  

  • 35. FDA perspectives on supplement use by patients on antithrombotic therapy: dietary supplement regulatory overview.
    Woo JJ
    Thromb Res; 2005; 117(1-2):193-6; discussion 201-7. PubMed ID: 16253311
    [No Abstract]   [Full Text] [Related]  

  • 36. Current FDA policy on use of human-labeled drugs in animals.
    Teske RH
    J Am Vet Med Assoc; 1993 May; 202(10):1632-3;discussion 1634. PubMed ID: 8514570
    [No Abstract]   [Full Text] [Related]  

  • 37. Anaphylaxis in an airplane after insecticide spraying.
    Vanden Driessche KS; Sow A; Van Gompel A; Vandeurzen K
    J Travel Med; 2010; 17(6):427-9. PubMed ID: 21050327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Legislative/Legal History of Prescription Drug Advertising and Promotion Regulation.
    Li S; Gibbs I
    J Pharm Pharm Sci; 2021; 24():381-389. PubMed ID: 34314671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic orphans.
    Shirkey H
    Pediatrics; 1999 Sep; 104(3 Pt 2):583-4. PubMed ID: 10469793
    [No Abstract]   [Full Text] [Related]  

  • 40. The impact of federal drug regulations on food animal practice.
    Jernigan AD; Hoffsis GF
    Vet Clin North Am Food Anim Pract; 1991 Nov; 7(3):651-8. PubMed ID: 1760754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.